US Drug Recall Register
Class II · Moderate risk Terminated Initiated Sep 12, 2019 (7 years ago)

Fluorescein

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

What was recalled

Fluorescein (PF) Lyophilized-For IV Use, Single Dose Vial, 500 mg/vial, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321676632

Recalling firm
KRS Global Biotechnology, Inc
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0052-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Fluorescein recalls

See all
Class II · Moderate risk Ongoing

BioGlo Fluorescein Sodium Ophthalmic Strips USP

Reason Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Wizcure Pharmaa Private Limited NDC 17238-900-11 D-0352-2026
Class II · Moderate risk Ongoing

Bio Glo Fluorescein Sodium Ophthalmic Strips USP

Reason Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Wizcure Pharmaa Private Limited NDC 17238-900-30 D-0351-2026
Class II · Moderate risk Ongoing

CHNaO Fluorescein Sodium Ophthalmic Strips

Reason Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Wizcure Pharmaa Private Limited NDC 83851-100-10 D-0350-2026
Class III · Low risk Ongoing

Fluorescein 2% Ophth

Reason Subpotent Drug

Boothwyn Pharmacy LLC D-0607-2025
Class II · Moderate risk Ongoing

Ful-Glo

Reason Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.

Nomax Inc NDC 17478-404-01 D-0465-2024